Lobbying

Alliance for A Stronger Fda's latest lobbying report covers Q4 2024, at $15K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations.

Alliance for A Stronger Fda

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Alliance for A Stronger Fda lobbying by quarter
Alliance for A Stronger Fda lobbying by quarter
QuarterAmountReports
Q4 2022$15K1
Q1 2023$15K1
Q2 2023$15K1
Q3 2023$15K1
Q4 2023$15K1
Q1 2024$15K1
Q2 2024$15K1
Q3 2024$15K1
Q4 2024$15K1
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Budget and appropriations$135K · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)9 reports
  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports
  • Office of Management & Budget (OMB)7 reports
  • Food & Drug Administration (FDA)4 reports

Firms it paid

Firm
HPS Group$135K9 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
25/01/21for Q4 2024HPS Group$15K
25/01/21for Q4 2024HPS Group$15K
24/12/01for Q3 2024HPS Group$15K
24/09/09for Q4 2023HPS Group$15K
24/08/13for Q2 2024HPS Group$15K
24/03/22for Q1 2024HPS Group$15K
23/12/03for Q3 2023HPS Group$15K
23/08/10for Q2 2023HPS Group$15K
23/05/04for Q1 2023HPS Group$15K
23/03/05for Q4 2022HPS Group$15K